Corporate
The Pharma Files: with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust
November 3, 2025Medical Communications, Research and Development Corporate, NHS, The Pharma Files, healthcare professionals, patient care, patients
Pharmafile chats with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust, about the best parts of his …
Turning a 10-Year Vision into a 10-Year Plan
October 27, 2025Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy
In the sixth of the Gateway to Local Adoption series, Visions4Health’s Head of Client Services, Jonny Savage, shares his views …
The Pharma Files: With Colin Williams from Astellas Pharma
October 5, 2025Medical Communications, Research and Development Astellas Pharma, Corporate, The Pharma Files, pm society
Pharmafile chats with Colin Williams, Head of Marketing Excellence, Global Capabilities, Learning & Development at Astellas Pharma about the best …
How can optichannel engagement drive return on investment across the product life cycle?
October 3, 2025Business Services, Consultancy Corporate, PharmaForceIQ, Pharmacy, chief strategy officer, optichannel engagement
HCPs and patients are demanding personalised, streamlined experiences. Hemal Somaiya, Chief Strategy Officer, PharmaForceIQ, discusses how optichannel engagement offers a …
From sickness to prevention: the case for population health management
October 3, 2025Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy
In the third of the Gateway to Local Adoption series, Visions4Health caught up with James Scott, Digital and Informatics Specialist …
Er-Kim to distribute CNX Therapeutics’ oncology drugs across Europe and Turkey
August 29, 2025Logistics & Distribution, Manufacturing and Production, Mergers and Acquisitions CNX Therapeutics, Corporate, Er-Kim, Oncology, central nervous system disorders, critical care
Turkish pharma company, Er-Kim, has signed a distribution agreement with CNX Therapeutics to expand access to a portfolio of oncology …
The Pharma Files: With Professor Hatim Abdulhussein from Health Innovation Kent Surrey Sussex
August 28, 2025Medical Communications, Research and Development Corporate, GP, Health Innovation Kent Surrey Sussex, The Pharma Files
Pharmafile chats with Priyanka Hinton, Customer Solutions Director at Chase People about the best parts of her job and her …
Terumo to acquire Oxford spin-out OrganOx in $1.5b deal
August 26, 2025Mergers and Acquisitions Corporate, OrganOx, Terumo, University of Oxford, organ transplantation
Japanese medical technology company Terumo has announced it will acquire OrganOx, a University of Oxford, UK, spin-out specialising in organ …
Neogap Therapeutics appoints Jonas Mattson to its board of directors
August 26, 2025Research and Development Corporate, Immunology, Neogap Therapeutics, Oncology, board of directors
Swedish biotech, Neogap Therapeutics, has appointed Jonas Mattson, an authority in cell therapy, to its board of directors. His appointment …
Johnson & Johnson commits $2bn to new manufacturing facility in North Carolina, US
August 22, 2025Manufacturing and Production Corporate, Fujifilm, Johnson & Johnson
Johnson & Johnson has announced a $2bn investment in a new manufacturing facility in Holly Springs, North Carolina, US, expanding …
Christopher Conway joins BioDuro board to strengthen global leadership
August 21, 2025Contract Manufacturing, Manufacturing and Production Bio X Cell, BioDuro, Corporate, board of directors, contract research development and manufacturing organisation
BioDuro has announced the appointment of Christopher Conway, CEO of Bio X Cell, to its board of directors, effective immediately. …
IQVIA and Veeva agree long-term partnerships to support service delivery
August 19, 2025Mergers and Acquisitions Corporate, IQVIA, Veeva Systems
IQVIA and Veeva Systems have announced the formation of global partnerships covering clinical and commercial services. IQVIA provides advanced analytics, …
KIFFIK Biomedical expands leadership team with two executive appointments
August 14, 2025Research and Development Chief Investment Officer, Corporate, Diagnostics, KIFFIK Biomedical, chief scientific officer
KIFFIK Biomedical has strengthened its leadership team with the appointments of Rene Veloso as chief investment officer and Reginald Swift …
Medidata appoints Lisa Moneymaker as chief strategy officer
August 13, 2025Clinical Trial Services, Research and Development Corporate, Medidata, chief strategy officer
Medidata has appointed Lisa Moneymaker as chief strategy officer to support the company’s long-term growth in the life sciences technology …
Sandoz signs renewable energy deal to supply 90% of European operations
August 13, 2025Mergers and Acquisitions Corporate, Elawan Energy, Sandoz, decarbonisation, renewable energy
Sandoz has entered into a ten-year virtual Power Purchase Agreement with Elawan Energy for the development of new solar projects …
Latest content
FibroFind appoints Lee Borthwick as CEO
